Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| Name |
Funds holding | Growth | Growth % |
Fund value |
|
|---|---|---|---|---|---|
|
OBX
126
Obsidian Therapeutics
OBX
$755M
| – | – | – | – |
|
127
Prime Medicine
PRME
$655M
| – | – | – | – |
|
|
SCTX
128
Scribe Therapeutics Inc
SCTX
$392M
| – | – | – | – |
|
|
SLBT
129
SL Science Holding Ltd
SLBT
$869M
| – | – | – | – |
|
|
TCBP
130
DELISTED
TC BioPharm (Holdings) plc American Depositary Shares
TCBP
| – | – | – | – |
|
131
DELISTED
Turnstone Biologics
TSBX
| – | – | – | – |
|